Top in GI: Esophageal hypervigilance scale, COVID-19 vaccination in IBD

A short form of the esophageal hypervigilance scale similarly measured symptom severity and quality of life compared with the longer test, according to a recent study. It was the top story in gastroenterology last week.

Another top story was about COVID-19 vaccination in patients with inflammatory bowel disease.

Read these and more top stories in gastroenterology below:

Short esophageal hypervigilance scale compares well with longer test

An esophageal hypervigilance and anxiety scale with fewer questions was reliable for measuring symptom severity and quality life, according to study results. Read more.

VIDEO: Benefit of COVID-19 vaccine outweighs risks in IBD patients

In this video, Freddy Caldera, DO, MS, assistant professor of medicine in the division of gastroenterology and hepatology at the University of Wisconsin School of Medicine and Public Health, said patients with inflammatory bowel disease should be vaccinated against COVID-19, but more research is needed to determine whether this population would benefit from booster doses. Watch video.

VIDEO: Probiotic drops glucose by 30% in type 2 diabetes

In this exclusive video, Colleen Cutcliffe, PhD, CEO and co-founder of Pendulum Therapeutics, discusses two strains of probiotics that the company is currently looking at. Watch video.

More data needed on minority populations to enhance IBD risk scores

Polygenic risk scores compiled using data from a multi-ethnic biobank helped improve predictions for inflammatory bowel disease, according to study results. Read more.

Liver transplant biliary strictures linked to increased rates of allograft rejection

Post-liver transplant biliary strictures correlated with increased rates of allograft rejection, allograft failure, infections and readmissions, according to a study published in the Journal of Gastroenterology and Hepatology. Read more.